搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
Managed Healthcare Executive
7 小时
Top 5 Formulary Watch Articles of 2024
Take a look at the best performing print articles of 2024. This year's top article spotlights the surge of mRNA vaccines ...
Managed Healthcare Executive
20 小时
Gene Therapy for Cardiomyopathies Presents Promising Alternative to Current Treatment
Cardiomyopathies currently have no cures, but many of these disorders are prime candidates for gene therapies. Treatments for ...
Managed Healthcare Executive
1 天
Top 5 Print Publication Articles of 2024
Take a look at the best performing print articles of 2024. This year's top article spotlights the surge of mRNA vaccines ...
Managed Healthcare Executive
2 天
FDA Approves First Once-Daily Generic of Victoza for Type 2 Diabetes
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
Managed Healthcare Executive
2 天
Evaluating Patient Attitudes Toward Conventional VMS Therapies
Kamilia Smith, MD, FACOG, NCMP, discusses how societal stigma and cultural misconceptions about menopause, combined with widespread misinformation about treatment options, create significant barriers ...
Managed Healthcare Executive
2 天
Trends and Transformation: Gene Therapies in Rare Blood Disorders
Gene therapies are revolutionizing treatment for hemophilia A and sickle cell disease; however, they are saddled with hefty ...
Managed Healthcare Executive
2 天
How the Contact Center Can Be a Driver of VBC Success
Historically, healthcare organizations have considered the contact center to be a cost center, a communications platform for ...
Managed Healthcare Executive
2 天
Alhemo Once-Daily Treatment for Hemophilia A, B with Inhibitors FDA Approved
The FDA recently approved the treatment by Novo Nordisk for hemophilia A or B with inhibitors, designed to prevent or reduce ...
Managed Healthcare Executive
3 天
FDA Approves Zepbound for Obese Adults with Sleep Apnea
Up to half of obstructive sleep apnea patients taking Zepbound had no symptoms after one year of treatment, averaging 25 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈